MD VANILLA B.V. X-17A-5 (2023-10-19) — Broker-dealer annual report

Full text of MD VANILLA B.V.'s X-17A-5 filed 2023-10-19 (period 2023-06-30). Broker-dealer annual report from SEC EDGAR — readable, searchable, and available as markdown for AI agents.

Document text (excerpt)

{0}------------------------------------------------ # Financial Statements and Supplemental Schedules Per Rule 17 A-5( e )(3) For the Year Ended June 30, 2023 {1}------------------------------------------------ # **Financial Statements and Supplemental Schedules Per Rule 17A-5(e)(3)** ## **For the Year Ended June 30, 2023** # **CONTENTS** **PAGE** | Facing Page -<br>Oath or Affirmation | 1 -<br>2 | |---------------------------------------------------------|----------| | Report of Independent Registered Public Accounting Firm | 3 | | Statement of Financial Condition | 4 | | Notes to Financial Statements | 5-8 | {2}------------------------------------------------ ![](_page_2_Picture_0.jpeg) Seen for legalization of the signatures (on the attached document) of Vladimir Vladislavovich Griniv, born on the 14th day of March 1986, and Remko Bastiaan Harrie Huibers, born on the 23rd day of July 1979, by me, Pepijn Jasper van Egmond, as legal substitute of Ilona Noelle van den Bergh, civil law notary in Amsterdam, the Netherlands. This statement explicitly contains no judgment as to the contents of this document. This statement may only be relied upon on the express condition that any issues of interpretation or liability there under will be governed by Dutch law and be brought exclusively before a Dutch Court and is subject to the Standard Terms of Engagement of Van Campen Liem (Van Campen & Partners N.V. and Liem & Partners N.V.)<sup>1</sup>which include a limitation of liability clause. Amsterdam, the Netherlands on the 13th day of October 2023. ![](_page_2_Picture_5.jpeg) <sup>1</sup>Filed at the court of Amsterdam, the Netherlands, on 25 May 2018 under number 50/2018. {3}------------------------------------------------ **UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549** | 0MB APPROVAL | |--------------------------| | 0MB Number: 3235-0123 | | Expires: Oct. 31, 2023 | | Estimated average burden | | hours per response: 12 | | | # **ANNUAL REPORTS FORM X-17A-5 PART** Ill | SEC FILE NUMBER | | |-----------------|--| | 8-70645 | | **FACING PAGE** **Information Required Pursuant to Rules 17a-S, 17a-12, and lBa-7 under the Securities Exchange Act of 1934** FILING FOR THE PERIOD BEGINNING **07/01/2022** AND ENDING **06/30/2023** MM/DD/VY MM/DD/VY **A. REGISTRANT IDENTIFICATION** NAME oF FIRM: MD Vanilla B.V. Maverick Derivatives TYPE OF REGISTRANT (check all applicable boxes): <sup>~</sup>Broker-dealer D Security-based swap dealer □ Major secur…

Read the full text as markdown

Other filings by this registrant

Original filing on SEC EDGAR (source of record)